SLNO
Soleno Therapeutics Inc
NASDAQ: SLNO · HEALTHCARE · BIOTECHNOLOGY
$52.78
+0.04% today
Updated 2026-04-29
Market cap
$2.73B
P/E ratio
135.33
P/S ratio
14.34x
EPS (TTM)
$0.39
Dividend yield
—
52W range
$29 – $90
Volume
3.8M
Soleno Therapeutics Inc (SLNO) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $2.51M | $1.59M | $8.40M | $8.20M | $5.56M | $39.02M | $43.15M | $38.17M | $64.98M | $35.55M | $26.50M | $180.69M | $330.97M |
| Cash & equivalents | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Current assets | $2.39M | $1.52M | $8.34M | $6.40M | $3.80M | $17.99M | $24.67M | $21.14M | $50.24M | $22.42M | $15.65M | $171.36M | $293.89M |
| Total liabilities | $36.71M | $39.45M | $18.73M | $4.98M | $2.13M | $12.49M | $12.74M | $23.23M | $19.43M | $17.76M | $16.15M | $23.18M | $85.86M |
| Current liabilities | $11.54M | $14.18M | $1.29M | $3.19M | $1.71M | $1.73M | $1.88M | $4.96M | $8.62M | $8.01M | $7.31M | $11.51M | $18.75M |
| Long-term debt | — | — | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — | $49.83M |
| Shareholder equity | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Retained earnings | $-53.39M | $-57.10M | $-70.98M | $-86.25M | $-98.31M | $-113.98M | $-127.03M | $-157.81M | $-182.44M | $-213.35M | $-237.42M | $-276.41M | $-452.26M |
| Accounts receivable | $150782.00 | $149605.00 | — | $156127.00 | $133337.00 | — | $64000.00 | — | — | — | — | — | — |
| Inventory | — | — | $109336.00 | $551008.00 | $660391.00 | $0.00 | — | — | — | — | — | — | — |
| Goodwill | — | — | $0.00 | $718003.00 | $718003.00 | $125530.00 | — | — | — | — | — | — | — |